Amarin

Amarin shares jump as FDA panel backs heart drug

US regulator’s advisory committee backs dramatic increase in market for purified fish oil drug Vascepa

Roll up, roll up: capitalism will drive cannabis legalisation in Ireland

Legalisation is coming, no matter what Irish policymakers may say now

Tariff threats to EU goods do little to curb gains in European share

BoI and Aryzta drag Iseq lower but Ryanair goes higher

Shares jump 15% in Ireland’s Amarin on hopes for heart drug

Strong increase in proft forecast on the back of sales of fish oil drug in the US

Amarin president named EY Entrepreneur of the Year

John Thero of the fish oil drug specialist recognised for company’s drug, Vascepa

Amarin jumps on FDA priority review for heart drug

Irish company’s Vascepa on track for earlier than expected approval

Irish VC group Fountain Healthcare Partners raises €118m

Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Amarin’s heartwarming bulletin for firm’s shareholders

Stock advances over fivefold in 12 months on evidence of medicine’s cardiovascular effect

Amarin to seek European approval for heart drug Vascepa

Clinical trials show Irish company’s fish-oil drug cut incidence of heart attacks and strokes

Dalata named company of the year at ‘Irish Times’ business awards

The Republic’s largest hotel group has more than 9,000 rooms across its portfolio

The Irish Times Company of the Year: the four finalists

Stripe, Dalata, Glanbia and Amarin shortlisted on back of standout years

Business 2018: the winners and the losers

The last 12 months proved to be another year of mixed fortunes in corporate Ireland

Irish firm Amarin confirms heart drug success

Some concern over neutrality of placebo and whether it might have boosted Vascepa data

Tetrarch buys 470 acres of Howth, bankers’ bonuses and Ryanair’s turbulent week

‘Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Amarin – an overnight success 10 years in the making

After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market

Amarin surges as trial results exceed expectations

Company’s Vascepa drug proves effective in reducing risk from stroke and heart attack

Most Read

1

‘The house was a mess, and the bill came to €9,000. It broke me’: Life as a small landlord

2

Back-to-school costs: ‘I was able to get my child’s uniform for free. I cried my eyes out with relief’

3

Una Mullally: There’s more to Sinn Féin’s sunny new outlook than meets the eye

4

‘My curiosity made me want to meet the wife of the man I was having an affair with’

5

Galway scientists develop system for removing clots from stroke patients in 20 minutes

You may also like...

The Irish Times ePaper